Worth reading
34Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
2980
Hundreds of millions of yenWording
Avoiding a definitive answer
How definitive the wording is.Contents of this document
Financial Results PresentationFiscal year ended March 2026 (FY2025)5 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Full-year earnings forecast
Orders received
3,000 Hundreds of millions of yen
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Met the initial forecastNew initiatives
- Establishment of the Growth Promotion Headquarters and development of a company-wide sales structure
- Entering into a strategic partnership with Idemitsu Kosan to commercialize mass production of solid electrolytes
- Investment in Heirloom
- Investment in Ammobia
- Construction and start of operations at a demonstration facility for a plant-based biofoundry
- Launch of development and deployment programs for core talent
Key KPIsA metric the company considers important as a management benchmark.
- Orders received2,980 Hundreds of millions of yen
- Order backlog6,131 Hundreds of millions of yenYear on year against the same period last yearDown ¥126.8 billion from the end of the previous fiscal year
- Cumulative order intake target under the medium-term plan9,500 Hundreds of millions of yen
Medium-term management plan targets
- TargetCumulative order intake targetTarget value¥950.0 billionTarget fiscal yearMedium-term plan period under Management Plan 2025Comparison with actual resultsFY2025 actual: ¥298.0 billion; remaining: ¥652.0 billion
- TargetAverage order backlog during the medium-term plan periodTarget value¥600 billionTarget fiscal yearMedium-term plan period under Management Plan 2025Comparison with actual resultsOrder backlog at 31 March 2026: ¥613.1 billion
Orders received and order backlog
Orders received
FY2025 Results¥298.0 billion
FY2026 Forecast¥300 billion
Order backlog
End of March 2026¥613.1 billion
Change from the end of the previous fiscal yearDown ¥126.8 billion from the end of the previous fiscal year
| Item | Details |
|---|---|
| Document type | Financial Results Presentation |
| Fiscal Period Covered | Fiscal year ended March 2026 (FY2025) |
| Full-year earnings forecast | Orders received 3,000 Hundreds of millions of yen |
| Self-assessment against the plan | Met the initial forecast |
| Key KPIs | Indicator name Orders received / Value 2,980 Hundreds of millions of yen / Year on year against the same period last year Not disclosed, Indicator name Order backlog / Value 6,131 Hundreds of millions of yen / Year on year against the same period last year Down ¥126.8 billion from the end of the previous fiscal year, Indicator name Cumulative order intake target under the medium-term plan / Value 9,500 Hundreds of millions of yen / Year on year against the same period last year Not disclosed |
| Medium-term management plan targets | Target Cumulative order intake target / Target value ¥950.0 billion / Target fiscal year Medium-term plan period under Management Plan 2025 / Comparison with actual results FY2025 actual: ¥298.0 billion; remaining: ¥652.0 billion, Target Average order backlog during the medium-term plan period / Target value ¥600 billion / Target fiscal year Medium-term plan period under Management Plan 2025 / Comparison with actual results Order backlog at 31 March 2026: ¥613.1 billion |
| Orders received and order backlog | Orders received FY2025 Results ¥298.0 billion / FY2026 Forecast ¥300 billion / Order backlog End of March 2026 ¥613.1 billion / Change from the end of the previous fiscal year Down ¥126.8 billion from the end of the previous fiscal year |
| New initiatives | Establishment of the Growth Promotion Headquarters and development of a company-wide sales structure, Entering into a strategic partnership with Idemitsu Kosan to commercialize mass production of solid electrolytes, Investment in Heirloom, Investment in Ammobia, Construction and start of operations at a demonstration facility for a plant-based biofoundry, Launch of development and deployment programs for core talent |
Items this document does not state (23)
Net SalesOperating profitOrdinary incomeNet incomeGross Profit MarginOperating profit marginSelling, general and administrative expensesResults for the three months of the current quarterProgress against full-year forecastSegment resultsBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.At Golden Pass LNG in the United States, construction and commissioning of Train 1 were completed and first LNG production was achieved. At Qatar NFE, work gradually resumed after a temporary suspension. While FY2025 order intake met the initial forecast, the company explained that uncertainty surrounding the situation in the Middle East has increased due to geopolitical risks and developments involving sanctions and diplomatic relations.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.